Related Experiment Video

Updated: Jul 19, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Glycogen synthase kinase-3beta binds to E2F1 and regulates its transcriptional activity

Gisela García-Alvarez1, Verònica Ventura, Oriol Ros

  • 1Departament de Bioquímica i Biologia Molecular, Facultat de Farmàcia, Universitat de Barcelona. Av. Diagonal 643, E-08028 Barcelona, Catalunya, Spain.

Biochimica Et Biophysica Acta
|October 20, 2006
PubMed

Insights

Glycogen synthase kinase 3 beta (GSK3beta) directly binds to the E2F1 transcription factor, regulating its activity. This interaction, independent of GSK3beta kinase activity, offers a novel mechanism controlling cell proliferation and apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Glycogen synthase kinase 3 beta (GSK3beta) and E2F1 are key regulators of cell proliferation and apoptosis.
  • GSK3beta is known to indirectly influence E2F activity by modulating cyclin D1 levels.

Purpose of the Study:

  • To investigate the direct interaction between GSK3beta and E2F1.
  • To elucidate the mechanism by which GSK3beta regulates E2F1 transcriptional activity.

Main Methods:

  • In vitro kinase assays to determine GSK3beta phosphorylation sites on E2F1.
  • Co-immunoprecipitation assays to detect in vivo protein binding.
  • Reporter gene assays to assess E2F1 transcriptional activity.
  • siRNA-mediated depletion of GSK3beta.

Main Results:

  • GSK3beta phosphorylates E2F1 at Serine 403 and Threonine 433 in vitro, but this phosphorylation is not observed in vivo.
  • GSK3beta directly binds to E2F1 in vivo.
  • Inactive GSK3beta inhibits E2F1 transcriptional activity, independent of Ser403/Thr433 phosphorylation.
  • Nuclear localization of GSK3beta enhances its regulatory capacity on E2F1.
  • GSK3beta depletion activates E2F1 transcriptional activity.

Conclusions:

  • GSK3beta directly interacts with the E2F1 transactivation domain.
  • This interaction provides a novel mechanism for regulating E2F1 activity, independent of GSK3beta's kinase function.
  • The findings suggest a new pathway controlling cell proliferation and apoptosis through direct GSK3beta-E2F1 interaction.

More Related Videos

Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...